PCDNA3-FlipGFP(TEV cleavage seq) T2A mCherry Citations (6)

Originally described in: Designing a green fluorogenic protease reporter by flipping a beta strand of GFP for imaging apoptosis in animals.
Zhang Q, Schepis A, Huang H, Yang J, Ma W, Torra J, Zhang SQ, Yang L, Wu H, Nonell S, Dong Z, Kornberg TB, Coughlin SR, Shu X J Am Chem Soc. 2019 Mar 1. doi: 10.1021/jacs.8b13042. PubMed Journal

---

Articles Citing PCDNA3-FlipGFP(TEV cleavage seq) T2A mCherry

Articles
Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL(pro) Reporter Assay. Froggatt HM, Heaton BE, Heaton NS. J Virol. 2020 Oct 27;94(22):e01265-20. doi: 10.1128/JVI.01265-20. Print 2020 Oct 27. PubMed
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay. Ma C, Sacco MD, Xia Z, Lambrinidis G, Townsend JA, Hu Y, Meng X, Szeto T, Ba M, Zhang X, Gongora M, Zhang F, Marty MT, Xiang Y, Kolocouris A, Chen Y, Wang J. ACS Cent Sci. 2021 Jul 28;7(7):1245-1260. doi: 10.1021/acscentsci.1c00519. Epub 2021 Jun 18. PubMed
Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir. Xia Z, Sacco M, Hu Y, Ma C, Meng X, Zhang F, Szeto T, Xiang Y, Chen Y, Wang J. ACS Pharmacol Transl Sci. 2021 Jun 9;4(4):1408-1421. doi: 10.1021/acsptsci.1c00099. eCollection 2021 Aug 13. PubMed
A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection. Gerber PP, Duncan LM, Greenwood EJ, Marelli S, Naamati A, Teixeira-Silva A, Crozier TW, Gabaev I, Zhan JR, Mulroney TE, Horner EC, Doffinger R, Willis AE, Thaventhiran JE, Protasio AV, Matheson NJ. PLoS Pathog. 2022 Feb 10;18(2):e1010265. doi: 10.1371/journal.ppat.1010265. eCollection 2022 Feb. PubMed
Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor. Tan H, Ma C, Wang J. Med Chem Res. 2022;31(7):1147-1153. doi: 10.1007/s00044-022-02903-0. Epub 2022 May 12. PubMed
Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease. Wang Q, Chen G, He J, Li J, Xiong M, Su H, Li M, Hu H, Xu Y. Int J Mol Sci. 2023 May 11;24(10):8633. doi: 10.3390/ijms24108633. PubMed

If you have published an article using this material, please email us at to have your article added to this page.